Testing Kit Detects Gene Variants Linked to Cystic Fibrosis
Asuragen Inc. has launched a testing kit for research use that is designed to detect pathogenic variants in the CFTR gene that cause cystic fibrosis.
Read MorePosted by Chris Wolski | Nov 12, 2021 | Molecular Diagnostic Analyzers, Respiratory Disease |
Asuragen Inc. has launched a testing kit for research use that is designed to detect pathogenic variants in the CFTR gene that cause cystic fibrosis.
Read MorePosted by Chris Wolski | Oct 28, 2021 | Middleware & Software |
The latest version of Tribun Health’s CaloPix 5 is an AI-powered computational pathology solution for diagnostics, prognosis, and drug development.
Read MorePosted by Chris Wolski | Oct 21, 2021 | Lung Cancer |
Data supports that a noninvasive nasal swab test can help physicians more accurately assess lung cancer risk in patients with lung nodules.
Read MorePosted by Chris Wolski | Oct 19, 2021 | Breast |
Quest Diagnostics will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx (Dako Omnis) immunohistochemistry companion diagnostic.
Read MorePosted by Chris Wolski | Oct 13, 2021 | Miscellaneous, Molecular Diagnostics |
California’s SB 535 prohibits insurers that already cover biomarker testing from requiring prior authorization for patients with advanced stage cancer.
Read More